What Countries are using Hydroxychloroquine?

As of March 2022, there have been more than 300 studies of Hydroxychloroquine, from more than 5,000 scientists in 50 countries. In the C19Early.com early treatment database, hydroxychloroquine is the most studied treatment for COVID-19.

Hydroxychloroquine (HCQ) is not effective when used very late with high dosages over a long period (RECOVERY/SOLIDARITY), effectiveness improves with earlier usage and improved dosing. Early treatment consistently shows positive effects. Negative evaluations typically ignore treatment time, often focusing on a subset of late stage studies.

The common confusion with Hydroxychloroquine appears to have been in part due to the bad publicity that hydroxychloroquine was suffering from, as it was targeted by the mainstream media, especially in relation to the presidential campaign in the US in 2020.

As of March 2022, hydroxychloroquine and Chloroquine have been officially adopted for early treatment in all or part of 36 countries (53 including non-government medical organizations).


Comeback of Hydroxychloroquine

This January 19, 2022; it’s therefore a bit of a surprise to see Hydroxychloroquine to re-appear in the FLCCC prevention and early treatment protocol.

The move follows the experience of several frontline doctors who found that Hydroxychloroquine is particularly useful to deal with Omicron, in combination with Ivermectin and other agents, as indicated in the FLCCC I-MASK+ protocol

So, with this move, we will expect less confusion and conflict among frontline doctors regarding the nature of the most appropriate agents to be included in early treatment protocols for COVID-19.

Hydroxychloroquine and Clinical Evidence (Updated)

Here’s a chart from c19early.com that shows that hydroxychloroquine performs better than ivermectin when given as early treatment in terms of risk reduction of dying from COVID-19:


The overall improvement for hydroxychloroquine is better than ivermectin (for early treatment); 74 % vs 44 % in terms of death rate. Importantly, hydroxychloroquine needs to be given 'early'

The difference in terms of effectiveness for hydroxychloroquine is distinctly different when given early vs late treatment (64% vs 20%), as shown in the summary chart below:


The evidence tracking on Hydroxychloroquine versus COVID-19 is available at c19hcq.com (constantly updated).

What Countries have Officially Adopted Hydroxychloroquine?

As of March 2022, hydroxychloroquine and Chloroquine have been officially adopted for early treatment in all or part of 36 countries (53 including non-government medical organizations).

The reference list below is arranged alphabetically by Country 

China - official - country-wide adoption - CQ is used instead of HCQ
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..

Egypt - official - country-wide adoption - Nov 30, 2020

Morocco - official - country-wide adoption

Nigeria - official - country-wide adoption

Turkey - official - country-wide adoption
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..

South Korea - official - country-wide adoption
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..

Venezuela - official - country-wide adoption
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..



Please send us corrections, updates, or comments below. Vaccines and early treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalised advice and details of risks and benefits based on your medical history and situation.
 
COVID-19 is a highly dynamic topic. Please refer to the latest FLCCC outpatient treatment protocol.


Related: What Countries are Using Ivermectin?

Comments

Popular posts from this blog

Dr Peter McCullough: Povidone Iodine, Oral and Nasal Hygiene (April 2022)

Dr Peter McCullough Early Treatment Protocol 2022

Find a Doctor to prescribe Hydroxychloroquine, Ivermectin and Early Outpatient Treatments

How to Make Povidone Iodine 1% Nasal Spray

America's Frontline Doctors Early Treatment Protocol and Contact a Physician 2022

Quercetin and Zinc: Zelenko Treatment Protocol (2022)

Dr Peter McCullough: Nasal Spray and Mouth Gargle to stop COVID?

Front Line Doctors Ivermectin Protocol for Prevention and Treatment of COVID-19 (March 2022)

Dr Peter McCullough: Fact Check and Debunked Theories

Dr. Peter McCullough Shares the Four Pillars of COVID-19 Care with Pennsylvania Lawmakers